Andrew Lo
CIK 1679076 · View on SEC EDGAR ↗
Insider
First SEC filing: Oct. 1, 2021 · Latest: Oct. 1, 2021
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 13 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
13 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | BBIO | S | 100,000 | $38.50 | $3,850,000 | 105,583 Indirect | -48.64% | Disposed | 120.0% (price as of 2026-08-19) |
| Dec. 30, 2021 | BBIO | P | 1,500 | $14.30 | $21,450 | 48,099 Direct | +3.22% | Acquired | 492.3% (price as of 2026-08-19) |
| Dec. 29, 2021 | BBIO | P | 6,000 | $12.90 | $77,400 | 46,599 Direct | +14.78% | Acquired | 556.6% (price as of 2026-08-19) |
| Dec. 3, 2021 | ABCL | P | 86,938 | $14.02 | $1,218,871 | 86,938 Direct | — | Acquired | -16.3% (price as of 2026-08-20) |
| Jan. 12, 2018 | ABUS | P | 664,000 | $100.00 | $66,400,000 | 1,164,000 Indirect | +132.80% | Acquired | -95.0% (price as of 2026-08-19) |
| Oct. 16, 2017 | ABUS | P | 500,000 | $100.00 | $50,000,000 | 500,000 Indirect | — | Acquired | -95.0% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2026 | BBIO | Stock Option (Right to Buy) | Common Stock (5,277) | $68.92 | June 21, 2036 | 5,277 | Acquired |
| June 20, 2025 | BBIO | Stock Option (Right to Buy) | Common Stock (8,425) | $41.73 | June 19, 2035 | 8,425 | Acquired |
| June 21, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (26,014) | $27.36 | June 20, 2034 | 26,014 | Acquired |
| June 21, 2023 | BBIO | Stock Option (right to buy) | Common Stock (51,501) | $16.75 | June 21, 2033 | 51,501 | Acquired |
| Dec. 1, 2022 | ABCL | Share Option (right to buy) | Common Shares (47,231) | $13.18 | Dec. 1, 2032 | 47,231 | Acquired |
| Sept. 15, 2022 | ROIV | Stock Option (Right to Buy) | Common Shares (71,850) | $3.50 | Sept. 14, 2032 | 71,850 | Acquired |
| June 22, 2022 | BBIO | Stock Option (right to buy) | Common Stock (104,921) | $8.45 | June 22, 2032 | 104,921 | Acquired |
| Dec. 3, 2021 | ABCL | Share Option (right to buy) | Common Shares (91,325) | $14.02 | Dec. 3, 2031 | 91,325 | Acquired |
| June 17, 2021 | BBIO | Stock Option (right to buy) | Common Stock (38,895) | $62.63 | June 16, 2031 | 38,895 | Acquired |
| June 23, 2020 | BBIO | Stock Option (Right to Buy) | Common Stock (101,223) | $32.62 | June 22, 2030 | 101,223 | Acquired |
| Jan. 12, 2018 | ABUS | Series A Participating Convertible Preferred Shares | Common shares, no par value | — | Oct. 16, 2021 | 664,000 | Acquired |
| Oct. 16, 2017 | ABUS | Series A Participating Convertible Preferred Shares | Common shares, no par value | — | Oct. 16, 2021 | 500,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.